TCR GENE THERAPY TARGETING ‘PUBLIC’ NEOANTIGENS RESULTING FROM COMMON DRIVER ONCOGENES

Session Name
Session 3: CAR/TCR design
Session Type
Plenary Session
Date
01.04.2022, Friday
Session Time
08:30 - 10:05
Room
Plenary room (Ballsaal)
Lecture Time
08:30 - 08:45
Presenter
  • Christopher Klebanoff, United States of America